✦ LIBER ✦

The impact of anti-angiogenic agents on cancer therapy

✍ Scribed by Dieter Marmé

Book ID: 106123305
Publisher: Springer-Verlag
Year: 2003
Tongue: English
Weight: 257 KB
Volume: 129
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-003-0488-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of copper chelation agents as

Evaluation of copper chelation agents as anti-angiogenic therapy

✍ Kevin Camphausen; Mary Sproull; Steve Tantama; Sandeep Sankineni; Tamalee Scott; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 200 KB

Potentiation of cytotoxic cancer therapi

Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents

✍ Beverly A. Teicher; Sylvia A. Holden; Gulshan Ara; Enrique Alvarez Sotomayor; Zh 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 724 KB

Molecular diagnosis of tumor angiogenesi

Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy

✍ Yasufumi Sato 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 273 KB

Anti-angiogenic Agents in Ovarian Cancer

Anti-angiogenic Agents in Ovarian Cancer: Dawn of a New Era?

✍ Joyce Liu; Ursula A. Matulonis 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 161 KB

Persistent vascular normalization as an

Persistent vascular normalization as an alternative goal of anti-angiogenic cancer therapy

✍ Yasufumi Sato 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

Impact of cancer therapy on survival

✍ E. H. Stonehill 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 365 KB 👁 3 views

Survival rates improved significantly for 28,036 lymphoma and leukemia patients studied between 1950 and 1973. Nine cancers reviewed demonstrated increased one, three and five year survival rates. Greatest improvement was acute lymphocytic leukemia survival. Least improvement was for chronic granulo